Life365, a leader in intelligent digital health infrastructure development and solution delivery, today announced that it has engaged Objective Capital Partners, LLC, to serve as a financial advisor to assist the Company in coordinating strategic capital and partnerships with the goal of maximizing the value of the strong intellectual property portfolio and digital health platform. The Life365 platform currently offers a range of solutions to engage health consumers at home, including a patented operating system for wearable health technology, software apps, integration to hundreds of connected medical devices, OTT set top box integration for Smart TVs, mobile / concierge personal safety services, Rapid Diagnostics pharmacy / home integration, and subscription e-commerce solutions for personalized care management.Continue reading
Author Archive: AZBio
New Study on Children With Autism and Developmental Delays Show TouchPoints Wearable Devices Reduced 72% of Disruptive and Self-Harming Behaviors
Data released from Ysgol Maes Y Coed, a special educational needs school in South Wales, UK showed a staggering reduction in problematic behaviors in case studies of children ages 7-14. Researchers tracked baseline behaviors for one week without TouchPoints, stress-relieving neuroscience wearables, and one week with the devices on the children during the entire school day.
Flinn Foundation Names New Leaders of Arizona’s Bioscience Roadmap Steering Committee
The HonorHealth vice president of research and a retired executive at W.L. Gore & Associates, Inc. have assumed new leadership roles with a statewide committee charged with advancing the biosciences in Arizona.Continue reading
ASU researchers address a primary cause of treatment failure for pancreatic cancer
As the second leading cause of death worldwide, cancer is a focal point in both clinical research and health care fields, but not all cancers are created equal. While some cancers are now much less deadly due to recent medical advances, other aggressive cancers remain highly resistant to currently available therapies.Continue reading
Makers of Brainwave Optimization Technologies® and Cereset™ Announce New Clinical Trial for Mild-Traumatic Brain Injury
Military personnel, athletes and accident victims who experience concussions can suffer from painful and debilitating conditions that impact everyday activities. Persisting symptoms from these mild Traumatic Brain Injuries (mTBI) can include sleep disturbance, anxiety, depression, foggy thinking, headaches, dizziness and behavioral issues.Continue reading
NuvOx Pharma’s NVX-208 Shows Positive Results in Phase Ib/II Stroke Trial
Positive results of NuvOx Pharma’s NVX-208 in the treatment of stroke have been published at the International Stroke Conference. The trial was sponsored by the University of Arkansas for Medical Sciences. William “Bill” Culp, MD, the principal investigator on the trial, said, “Such strong safety and promising efficacy results meet our highest hopes for this small trial. Expanded trials are fully warranted.”Continue reading
Researchers to Compete in ‘Shark Tank,’ Demo Technology, More at Research Day, Feb. 13
University of Arizona researchers will compete in a “Shark Tank”-style competition, demonstrate their medical technology and more during Research Day, a first-of-its-kind event coordinated by the UA College of Medicine – TucsonContinue reading
Tucson High Schoolers to Explore Careers in Medicine, Other Health Professions, Feb. 20
Local high school students will practice their health-care skills, such as CPR and ultrasound imaging, during “A Pathway to Success,” an interactive health-care career fair spearheaded by residents at the University of Arizona College of Medicine – Tucson South Campus.Continue reading